Lanean...
Antiviral applications of RNAi for coronavirus
Until the appearance of severe acute respiratory syndrome (SARS), caused by the SARS coronavirus (SARS-CoV) in early 2003, coronavirus infection was not considered to be serious enough to be controlled by either vaccination or specific antiviral therapy. It is now believed that the availability of a...
Gorde:
| Argitaratua izan da: | Expert Opin Investig Drugs |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2006
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103689/ https://ncbi.nlm.nih.gov/pubmed/16433589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.15.2.89 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|